Compare Stocks: AMIX, TELA, ARAY, and ELUT

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AMIX Autonomix Medical	$6.85 -0.1%	$6.79	$2.44 ▼ $32.55	$6.66M	-1.17	11.62 million shs	208,364 shs
ARAY Accuray	$0.28 +1.0%	$0.28	$0.22 ▼ $2.10	$33.10M	1.39	1.43 million shs	711,922 shs
ELUT Elutia	$0.94 +9.4%	$0.94	$0.50 ▼ $2.50	$36.81M	0.87	58,930 shs	67,125 shs
TELA TELA Bio	$0.64 -5.0%	$0.78	$0.50 ▼ $2.00	$28.93M	1.34	127,736 shs	247,788 shs

7 Stocks That Could Lead the Next Market Boom

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AMIX Autonomix Medical	-0.15%	-31.77%	+33.53%	+0.37%	-70.61%
ARAY Accuray	+0.98%	-2.39%	+1.20%	+3.04%	-81.33%
ELUT Elutia	+9.38%	+10.71%	-1.97%	-8.64%	-56.44%
TELA TELA Bio	-4.97%	-25.93%	-17.95%	-28.81%	-56.02%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AMIX Autonomix Medical	$6.85 -0.1%	$6.79	$2.44 ▼ $32.55	$6.66M	-1.17	11.62 million shs	208,364 shs
ARAY Accuray	$0.28 +1.0%	$0.28	$0.22 ▼ $2.10	$33.10M	1.39	1.43 million shs	711,922 shs
ELUT Elutia	$0.94 +9.4%	$0.94	$0.50 ▼ $2.50	$36.81M	0.87	58,930 shs	67,125 shs
TELA TELA Bio	$0.64 -5.0%	$0.78	$0.50 ▼ $2.00	$28.93M	1.34	127,736 shs	247,788 shs

7 Stocks That Could Lead the Next Market Boom

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AMIX Autonomix Medical	-0.15%	-31.77%	+33.53%	+0.37%	-70.61%
ARAY Accuray	+0.98%	-2.39%	+1.20%	+3.04%	-81.33%
ELUT Elutia	+9.38%	+10.71%	-1.97%	-8.64%	-56.44%
TELA TELA Bio	-4.97%	-25.93%	-17.95%	-28.81%	-56.02%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AMIX Autonomix Medical	2.00	Hold	$42.00	513.14% Upside
ARAY Accuray	1.67	Reduce	$2.00	618.91% Upside
ELUT Elutia	2.00	Hold	$6.00	537.62% Upside
TELA TELA Bio	2.40	Hold	$2.20	241.46% Upside

Current Analyst Ratings Breakdown

Latest AMIX, TELA, ARAY, and ELUT Analyst Ratings

Date	Company	Brokerage	Action	Rating
8/4/2026	ARAY Accuray	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
7/28/2026	AMIX Autonomix Medical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E) ➝ Sell (E+)
7/23/2026	ELUT Elutia	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold (C-) ➝ Sell (D+)
7/17/2026	TELA TELA Bio	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
7/10/2026	AMIX Autonomix Medical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (E+) ➝ Sell (E)
7/8/2026	ARAY Accuray	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Neutral
7/7/2026	ELUT Elutia	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (D+) ➝ Hold (C-)
6/23/2026	AMIX Autonomix Medical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E) ➝ Sell (E+)
6/17/2026	ELUT Elutia	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold (C-) ➝ Sell (D+)
6/3/2026	AMIX Autonomix Medical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (E+) ➝ Sell (E)
6/2/2026	AMIX Autonomix Medical	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold

(Data available from 8/15/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AMIX Autonomix Medical	N/A	N/A	N/A	N/A	$10.85 per share	N/A
ARAY Accuray	$428.57M	0.08	$0.05 per share	6.18	$0.72 per share	0.39
ELUT Elutia	$12.29M	3.28	N/A	N/A	$0.65 per share	1.45
TELA TELA Bio	$79.91M	0.36	N/A	N/A	($0.35) per share	-1.84

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AMIX Autonomix Medical	-$16.72M	-$59.03	N/A	N/A	N/A	N/A	-231.18%	-187.69%	N/A
ARAY Accuray	-$1.59M	-$0.37	N/A	N/A	N/A	-10.76%	-79.43%	-10.38%	8/19/2026 (Estimated)
ELUT Elutia	$53.38M	$0.95	0.99	N/A	N/A	426.93%	-1,071.47%	-45.79%	N/A
TELA TELA Bio	-$38.83M	-$0.77	N/A	N/A	N/A	-51.53%	-4,549.79%	-59.39%	N/A

Latest AMIX, TELA, ARAY, and ELUT Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/19/2026	Q4 2026	ARAY Accuray	-$0.03	N/A	N/A	N/A	$105.30 million	N/A
8/13/2026	Q2 2026	ELUT Elutia	-$0.15	-$0.17	-$0.02	-$0.17	$2.90 million	$2.43 million
8/12/2026	Q1 2027	AMIX Autonomix Medical	-$6.40	-$5.02	+$1.38	-$5.02	N/A	N/A
8/10/2026	Q2 2026	TELA TELA Bio	-$0.1738	-$0.20	-$0.0262	-$0.20	$20.01 million	$19.29 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
AMIX Autonomix Medical	N/A	N/A	N/A	N/A	N/A
ARAY Accuray	N/A	N/A	N/A	N/A	N/A
ELUT Elutia	N/A	N/A	N/A	N/A	N/A
TELA TELA Bio	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AMIX Autonomix Medical	N/A	4.45	4.45
ARAY Accuray	3.21	1.42	0.66
ELUT Elutia	N/A	2.05	1.94
TELA TELA Bio	8.82	2.99	2.92

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AMIX Autonomix Medical	10.78%
ARAY Accuray	64.08%
ELUT Elutia	74.03%
TELA TELA Bio	94.35%

Insider Ownership

Company	Insider Ownership
AMIX Autonomix Medical	6.20%
ARAY Accuray	4.36%
ELUT Elutia	17.80%
TELA TELA Bio	5.10%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AMIX Autonomix Medical	1	971,000	911,000	N/A
ARAY Accuray	1,040	118.96 million	113.78 million	Optionable
ELUT Elutia	180	42.78 million	35.17 million	Not Optionable
TELA TELA Bio	120	44.90 million	42.61 million	Optionable

AMIX, TELA, ARAY, and ELUT Headlines

Recent News About These Companies

Tela Bio outlines 9- to 12-month sales ramp while withdrawing full-year revenue guidance

August 12 at 5:56 PM | seekingalpha.com

TELA Bio Q2 Earnings Call Highlights

August 12 at 4:03 AM | americanbankingnews.com

TELA Bio, Inc. (TELA) Q2 2026 Earnings Call Transcript

August 11, 2026 | seekingalpha.com

TELA Bio, Inc. (TELA) Reports Q2 Loss, Lags Revenue Estimates

August 10, 2026 | zacks.com

TELA Bio Reports Second Quarter 2026 Financial Results

August 10, 2026 | markets.businessinsider.com

TELA Bio (TELA) Expected to Post Quarterly Earnings on Monday

August 9, 2026 | americanbankingnews.com

Tela Bio names new CEO as Malvern medtech company eyes next growth phase

August 5, 2026 | msn.com

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

August 5, 2026 | globenewswire.com

Tela Bio names new CEO as co-founder exits after 14 years

August 4, 2026 | bizjournals.com

TELA Bio Appoints Heather Getz as Chief Executive Officer and Director

August 4, 2026 | quiverquant.comQ

TELA Bio Announces Appointment of Heather Getz as Chief Executive Officer and Director

August 4, 2026 | globenewswire.com

TELA Bio to Participate in the Canaccord Genuity 46th Annual Growth Conference

July 29, 2026 | globenewswire.com

TELA Bio to Announce Second Quarter 2026 Financial Results

July 20, 2026 | globenewswire.com

A perfect match

July 16, 2026 | bbc.comB

TELA Bio Healthcare Story Faces New Market Scrutiny

May 15, 2026 | kalkinemedia.comK

Earnings Release: Here's Why Analysts Cut Their TELA Bio, Inc. (NASDAQ:TELA) Price Target To US$2.25

May 15, 2026 | finance.yahoo.com

TELA Bio Inc (TELA) Q1 2026 Earnings Call Highlights: Strong European Growth and Strategic U.S. ...

May 13, 2026 | finance.yahoo.com

TELA Bio, Inc. (TELA) Q1 2026 Earnings Call Transcript

May 12, 2026 | seekingalpha.com

TELA Bio, Inc. (TELA) Reports Q1 Loss, Beats Revenue Estimates

May 12, 2026 | zacks.com

TELA Bio Reports First Quarter 2026 Financial Results

May 12, 2026 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

AMIX, TELA, ARAY, and ELUT Company Descriptions

Autonomix Medical NASDAQ:AMIX

$6.85 -0.01 (-0.15%)

Closing price 08/14/2026 04:00 PM Eastern

Extended Trading

$6.85 0.00 (-0.06%)

As of 08/14/2026 07:57 PM Eastern

Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.

Accuray NASDAQ:ARAY

$0.28 +0.00 (+0.98%)

Closing price 08/14/2026 04:00 PM Eastern

Extended Trading

$0.29 +0.01 (+3.16%)

As of 08/14/2026 07:54 PM Eastern

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. It offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy platform, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.

Elutia NASDAQ:ELUT

$0.94 +0.08 (+9.38%)

Closing price 08/14/2026 04:00 PM Eastern

Extended Trading

$0.94 +0.00 (+0.43%)

As of 08/14/2026 07:34 PM Eastern

Elutia Inc., a commercial-stage company, develops and commercializes drug-eluting biologics products for neurostimulation, wound care, and breast reconstruction in the United States. The company operates in three segments: Device Protection; Women's Health; and Cardiovascular. It offers CanGaroo Envelope, which is used to accommodate cardiac implantable electronic devices, such as pacemakers and internal defibrillators. The company also develops CanGarooRM, a combination of the CanGaroo envelope with antibiotics, to reduce the risk of infection after surgical implantation of an electronic device. In addition, it provides ProxiCor for cardiac tissue repair and pericardial closure; Tyke, an extracellular material that is used in the repair of cardiac structures for neonate and infant patients; and VasCure, a patch material to repair or reconstruct the peripheral vasculature. Further, the company offers SimpliDerm, which uses human acellular dermal matrices for tissue repair and reconstruction in various applications, such as sports medicine, hernia repair, trauma reconstruction, and breast reconstruction surgeries following mastectomy. It serves hospitals and healthcare facilities through its direct sales force, independent sales agents, and distributors. The company was formerly known as Aziyo Biologics, Inc. and changed its name to Elutia Inc. in September 2023. Elutia Inc. was incorporated in 2015 and is headquartered in Silver Spring, Maryland.

TELA Bio NASDAQ:TELA

$0.64 -0.03 (-4.97%)

Closing price 08/14/2026 04:00 PM Eastern

Extended Trading

$0.68 +0.04 (+5.70%)

As of 08/14/2026 07:34 PM Eastern

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest AMIX, TELA, ARAY, and ELUT Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest AMIX, TELA, ARAY, and ELUT Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

AMIX, TELA, ARAY, and ELUT Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

AMIX, TELA, ARAY, and ELUT Company Descriptions

Autonomix Medical NASDAQ:AMIX

Accuray NASDAQ:ARAY

Elutia NASDAQ:ELUT

TELA Bio NASDAQ:TELA

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest AMIX, TELA, ARAY, and ELUT Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest AMIX, TELA, ARAY, and ELUT Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

AMIX, TELA, ARAY, and ELUT Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

AMIX, TELA, ARAY, and ELUT Company Descriptions

Autonomix Medical NASDAQ:AMIX

Accuray NASDAQ:ARAY

Elutia NASDAQ:ELUT

TELA Bio NASDAQ:TELA

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools